4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001209191-18-039183
Options or other derivatives
- Director acquired 258,171 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| SANDAGE BOBBY W. JR., PHD. Director | 2018-06-20 | Grant or award · Stock Option (Right to Buy) | +258,171 | 258,171 | D | ||
Loading xslF345X03/doc4.xml…